Fournet, Florence
Adja, Akre M.
Adou, Kouassi A.
Dahoui, Milossé M. C.
Coulibaly, Baba
Assouho, Konan F.
Zoh, Dounin D.
Koné, Moussa
Koné, Aboubacar
Niamien, Koffi L.
Cornelie, Sylvie
Tia, Emmanuel
Moiroux, Nicolas
Funding for this research was provided by:
Institut de Recherche pour le Développement
Agence Nationale de la Recherche (ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01, ANR 17 CE 22 0007 01)
Article History
Received: 18 April 2022
Accepted: 15 September 2022
First Online: 28 September 2022
Declarations
:
: The protocol of this study was reviewed and approved by the National Life Sciences and Health Ethics Committee (Agreement No. 156-18/MSHP/CNESVS-km of 14 November 2018). The participants who collected the mosquitoes and their supervisors all gave their written informed consent. They received a vaccine against yellow fever as a prophylactic measure. Participants were treated free of charge for malaria according to WHO recommendations.
: Not applicable.
: The authors declare no competing interests.